Editor in Chief

Dr. Qingsheng Li. PhD. is an Associate professor at Nebraska Center for Virology School of Biological Sciences, University of Nebraska-Lincoln. His research is focused on studying HIV-1 pathogenesis, transmission and prevention using single cell in situ analyses and in vivo SIV-rhesus macaque and humanized-BLT (bone marrow liver and thymus) mouse models of HIV-1 infection. He is a Professional…

Name : Qingsheng Li
University : University of Nebraska-Lincoln

Indexing and Listing

          

PubMed Indexed Articles

  • Homeodomain Transcription Factor Msx-2 Regulates Uterine Progenitor Cell Response to Diethylstilbestrol

    The fate of mouse uterine epithelial progenitor cells is determined between postnatal days 5 to 7. Around this critical time window, exposure to an endocrine disruptor, diethylstilbestrol (DES), can profoundly alter uterine cytodifferentiation. We have shown previously that a homeo domain transcription factor MSX-2 plays an important role in DES-responsiveness…

    View more
  • Brain Uptake of Neurotherapeutics after Intranasal Delivery in Mice

    There is a growing global prevalence of neurodegenerative diseases such as Alzheimer’s disease and dementia. Current treatment for neurodegenerative diseases is limited due to the blood brain barrier’s ability to restrict the entry of therapeutics to the brain. In that context, direct delivery of drugs from nose to brain has gained emerging interest…

    View more
  • Current Studies of Immunotherapy on Glioblastoma

    Glioblastoma is a form of brain tumor with a very high morbidity and mortality. Despite decades of research, the best treatments currently in clinical practice only extend survival by a number of months. A promising alternative to conventional treatment for glioblastomas is immunotherapy. Although proposed over a century ago, the field of cancer immunotherapy…

    View more

Testimonial

Paul G Mathew, Harvard Vanguard Medical Associates

It was a pleasure to publish my manuscript with the Journal of Neurology and Neurosurgery. I found the peer review process was rigorous, and helped to improve the overall quality of my manuscript without being too tedious. The editorial staff, particularly Divakar Sadam, was very responsive to all of my concerns, and usually corresponded within 24 hours of a query. I had an overall excellent experience, and I hope that the journal is indexed in PubMed in the near future.